Observational Study
Copyright ©The Author(s) 2025.
World J Clin Oncol. Apr 24, 2025; 16(4): 104827
Published online Apr 24, 2025. doi: 10.5306/wjco.v16.i4.104827
Table 1 Detailed characteristics of patients recruited in the study
Characteristic
Details
Concomitant medications
Total number of patients10
Gender6 females, 4 males
Mean age65 years
Age range50-80 years
Cancer typesLung cancer: 4 patients (40%)Cisplatin; Paclitaxel; Ondansetron; Dexamethasone; Diclofenac
Breast cancer: 3 patients (30%)Doxorubicin; Cyclophosphamide; Zolendronic acid; Letrozole;Anastrozole; Dexamethasone; Diclofenac
Prostate cancer: 2 patients (20%)Leuprolide; Enzalutamide; Zolendronic acid; Diclofenac
Pancreatic cancer: 1 patient (10%)Gemcitabine; 5-Fluorouracil; Dexamethasone; Diclofenac